• Rallybio has laid off 45% of its workforce in 2024 and plans to cut an additional 40%. • The company has faced major setbacks, with its stock losing nearly all value since its $81 million IPO four years ago. • The layoffs reflect deep... — read more
45% of workforce to be laid off
“Rallybio Corporation is laying off nearly half of its workforce—19 people—in a bid to extend its cash runway into 2026, the New Haven–based biopharma announced Tuesday. According to the announcement, Rallybio will now prioritize development of two... — read more